ENVX Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

10.34M

+6.36%

-0.238

+19.06%

9.72M

+90.69%

-0.207

+72.23%

12.28M

+64.42%

-0.223

+1.51%

Estimates Revision

The market is revising Downward the revenue expectations for Enovix Corporation (ENVX) for FY2025, with the revenue forecasts being adjusted by -5.24% over the past three months. During the same period, the stock price has changed by -34.38%.

Revenue Estimates for FY2025

Revise Downward

-5.24%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+14.16%

In Past 3 Month

Stock Price

Go Down

-34.38%

In Past 3 Month

9 Analyst Rating

Wall Street analysts forecast ENVX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENVX is 19.00 USD with a low forecast of 10.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

7 Buy

2 Hold

0 Sell

Strong Buy

Current: 0.000

Low

10.00

Averages

19.00

High

25.00

Current: 0.000

Low

10.00

Averages

19.00

High

25.00

Northland

Gus Richard

Outperform

Underperform

downgrade

$25 -> $16

2025-11-17

Reason

Northland

Gus Richard

Price Target

$25 -> $16

2025-11-17

downgrade

Outperform

Underperform

Reason

Northland analyst Gus Richard lowered the firm's price target on Enovix to $16 from $25 and keeps an Outperform rating on the shares. The firm, which is adjusting estimates for a slower ramp of mobile phone revenue, calls the delay of the mobile phone ramp "disappointing," particularly after Enovix raised over $500M in Q3. The firm, which contends that it is "very likely consensus estimates for CY26 are too high," notes that its own estimates for calendar year 2026 are the "Street low."

JPMorgan

Neutral

downgrade

$12 -> $10

2025-11-12

Reason

JPMorgan

Price Target

$12 -> $10

2025-11-12

downgrade

Neutral

Reason

JPMorgan lowered the firm's price target on Enovix to $10 from $12 and keeps a Neutral rating on the shares. The firm updated the company's model.

Canaccord

Buy

maintain

$22 -> $21

2025-11-06

Reason

Canaccord

Price Target

$22 -> $21

2025-11-06

maintain

Buy

Reason

Canaccord lowered the firm's price target on Enovix to $21 from $22 and keeps a Buy rating on the shares. The firm says the company's statement that it sees "additional lifecycle testing following...design revision" has added about 3 to 6 months to the ramp schedule, but while it admits to being "a little frustrated with another ramp delay," it is comforted by what it views as Enovix's strong management team, great technology, and healthy balance sheet.

Canaccord

George Gianarikas

Buy

downgrade

$22 -> $21

2025-11-06

Reason

Canaccord

George Gianarikas

Price Target

$22 -> $21

2025-11-06

downgrade

Buy

Reason

Canaccord analyst George Gianarikas lowered the firm's price target on Enovix to $21 from $22 and keeps a Buy rating on the shares. The firm noted the quarter introduced another delay in the "hockey stick" P&L they have been anticipating and tell investors to continue to be patient.

Cantor Fitzgerald

Overweight

downgrade

$30 -> $25

2025-11-06

Reason

Cantor Fitzgerald

Price Target

$30 -> $25

2025-11-06

downgrade

Overweight

Reason

Cantor Fitzgerald lowered the firm's price target on Enovix to $25 from $30 and keeps an Overweight rating on the shares. Enovix missed the mark in Q3, reporting a cycle life issue with battery samples that led to a roughly one-quarter qualification push-out with its first smartphone customer, Honor, the analyst tells investors in a research note. Enovix is confident that commercial smartphone production will begin in Q2, Cantor notes, adding that the company is progressing nicely with smartphone OEMs and toward mass commercialization.

Oppenheimer

Outperform

downgrade

$26 -> $24

2025-11-06

Reason

Oppenheimer

Price Target

$26 -> $24

2025-11-06

downgrade

Outperform

Reason

Oppenheimer lowered the firm's price target on Enovix to $24 from $26 and keeps an Outperform rating on the shares. The firm notes the company announced continued Fab 2 progress along with naming its lead smartphone OEM partner as yields in each of its production zones improved, but management indicated chemistry adjustments had not yet been validated for cycle life requirements delaying revenue ramp. Oppenheimer views cycle-life delays as not uncommon in new battery commercialization as testing can be cumbersome and lengthy. The firm is pushing out its ramp expectations for Fab 2 by two quarters and moderating growth for 2027/28 as a result. But it continues to believe Enovix's architecture offers unique and valuable performance for edge devices and that the company is well positioned as a unit play on powering distributed compute.

Valuation Metrics

The current forward P/E ratio for Enovix Corp (ENVX.O) is -8.72, compared to its 5-year average forward P/E of -14.59. For a more detailed relative valuation and DCF analysis to assess Enovix Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-14.59

Current PE

-8.72

Overvalued PE

-4.22

Undervalued PE

-24.96

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-19.57

Current EV/EBITDA

-16.08

Overvalued EV/EBITDA

-9.47

Undervalued EV/EBITDA

-29.67

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

295.99

Current PS

32.35

Overvalued PS

566.28

Undervalued PS

25.70

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds areBuying! The buying amount has increased 2618.8% over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

ENVX News & Events

Events Timeline

No data

News

7.0

2025-12-24PRnewswire

Halper Sadeh Investigates Enovix Corp. for Potential Shareholder Rights Breach

8.0

2025-12-23NASDAQ.COM

Enovix Corp Sees Options Trading Volume Exceeding 103.5% of Daily Average

7.0

2025-12-18Globenewswire

Halper Sadeh Investigates Enovix Corp. Officers for Potential Fiduciary Breach

People Also Watch

Frequently Asked Questions

What is Enovix Corp (ENVX) stock price today?

The current price of ENVX is 7.92 USD — it has increased 0.13 % in the last trading day.

What is Enovix Corp (ENVX)'s business?

Enovix Corporation is a global high-performance battery company. The Company designs, develops, manufactures, and commercializes lithium-ion (Li-ion) battery cells that increase the amount of energy density and storage capacity relative to conventional battery cells. In addition to designing its batteries, it also develops the advanced manufacturing processes needed to produce its batteries in high volume. It targets a smaller group of large customers that require custom cells. Its technology roadmap is built around a structured progression of battery nodes, with each new generation, such as the EX-1M, EX-2M, EX-3M and so on. The Company, through Routejade, Inc. (Routejade), supplies batteries for wearables, medical devices, headsets, activity trackers, and industrial equipment. Routejade offers product categories, including PD series, FLPB and ASDB series, and SLPB series. The PD series consists of rechargeable coin cells commonly used in healthcare and IoT applications.

What is the price predicton of ENVX Stock?

What is Enovix Corp (ENVX)'s revenue for the last quarter?

Enovix Corp revenue for the last quarter amounts to 7.99M USD, increased 85.08 % YoY.

What is Enovix Corp (ENVX)'s earnings per share (EPS) for the last quarter?

Enovix Corp. EPS for the last quarter amounts to -0.26 USD, increased 100.00 % YoY.

What changes have occurred in the market's expectations for Enovix Corp (ENVX)'s fundamentals?

How many employees does Enovix Corp (ENVX). have?

Enovix Corp (ENVX) has 570 emplpoyees as of January 10 2026.

What is Enovix Corp (ENVX) market cap?

Today ENVX has the market capitalization of 1.71B USD.